Originalpublikationen
Mueller A, Brieske C, Schinke S, Csernok E, Gross WL, Hasselbacher K, Voswinkel J, Holl-Ulrich K. Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis. Arthritis Res Ther. 2014 Feb 20;16(1):R55. doi: 10.1186/ar4490.
Herlyn K, Buckert F, Gross WL, Reinhold-Keller E. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology (Oxford). 2014 May;53(5):882-9. doi: 10.1093/rheumatology/ket440. Epub 2014 Jan 13.
Mueller A, Brieske C, Schinke S, Csernok E, Gross WL, Hasselbacher K, Voswinkel J, Holl-Ulrich K. Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis. Arthritis Res Ther. 2014 Feb 20;16(1):R55. doi: 10.1186/ar4490.
Gross WL, Schreiber S. [Genetic architecture of chronic inflammatory diseases]. Internist (Berl). 2014 Feb;55(2):121-3. doi: 10.1007/s00108-013-3302-z.
Holle JU, Gross WL. [Genetic risk factors for vasculitis].[Article in German] Internist (Berl). 2014 Feb;55(2):128-34. doi: 10.1007/s00108-013-3305-9.
Wieczorek S, Holle JU, Cohen Tervaert JW, Harper L, Moosig F, Gross WL, Epplen JT.The SEM6A6 locus is not associated with granulomatosis with polyangiitis or other forms of antineutrophil cytoplasmic antibody-associated vasculitides in Europeans: comment on the article by Xie et al. Arthritis Rheumatol. 2014 May;66(5):1400-1. doi: 10.1002/art.38367.
Márquez A, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Fernández-Contreras ME, Ramentol M, Morado IC, Narváez J, Gómez-Vaquero C, Martínez-Taboada VM, Ortego-Centeno N, Sopeña B, Monfort J, García-Villanueva MJ, Caminal-Montero L, de Miguel E, Blanco R; Spanish GCA Consortium, Palm O, Molberg O, Latus J, Braun N, Moosig F, Witte T, Beretta L, Santaniello A, Pazzola G, Boiardi L, Salvarani C, González-Gay MA, Martín J. Influence of the IL17A locus in giant cell arteritis susceptibility. Ann Rheum Dis. 2014 Sep;73(9):1742-5. doi: 10.1136/annrheumdis-2014-205261. Epub 2014 Jun 11.
Prüßmann J, Prüßmann W, Recke A, Rentzsch K, Juhl D, Henschler R, Müller S, Lamprecht P, Schmidt E, Csernok E, Görg S, Stöcker W, Zillikens D, Ibrahim SM, Ludwig RJ. Co-occurrence of autoantibodies in healthy blood donors. Exp Dermatol. 2014 Jul;23(7):519-21. doi: 10.1111/exd.12445.
Márquez A, Solans R, Hernández-Rodríguez J, Cid MC3, Castañeda S, Ramentol M, Rodriguez-Rodriguez L, Narváez J, Blanco R, Ortego-Centeno N; Spanish GCA Consortium, Palm O, Diamantopoulos AP, Braun N, Moosig F, Witte T, Beretta L, Lunardi C, Cimmino MA, Vaglio A, Salvarani C, González-Gay MA, Martín J. A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA. PLoS One. 2014 Nov 19;9(11):e113476. doi: 10.1371/journal.pone.0113476. eCollection 2014.
Mohammad AJ, Hot A, Arndt F, Moosig F, Guerry MJ, Amudala N, Smith R, Sivasothy P, Guillevin L, Merkel PA, Jayne DR. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Ann Rheum Dis. 2014 Dec 2. pii: annrheumdis-2014-206095. doi: 10.1136/annrheumdis-2014-206095. [Epub ahead of print]